Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Jul 2015 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. S&P 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Nippon India US Equity Opportunities Fund |
|---|---|
| 28 Jul 2015 | ₹100.00 |
| 29 Jun 2016 | ₹101.36 |
| 01 Jun 2017 | ₹116.74 |
| 03 May 2018 | ₹132.69 |
| 05 Apr 2019 | ₹156.51 |
| 07 Mar 2020 | ₹172.01 |
| 07 Feb 2021 | ₹228.52 |
| 09 Jan 2022 | ₹260.18 |
| 12 Dec 2022 | ₹225.41 |
| 14 Nov 2023 | ₹266.17 |
| 16 Oct 2024 | ₹338.22 |
| 17 Sep 2025 | ₹378.34 |
| 20 Aug 2026 | ₹436.69 |
| Metric | Nippon India · Regular NAV ₹42.38 Very High risk ★★★☆☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +19.07% | +5.83% | |
| +18.94% | +15.63% | |
| +11.03% | +13.23% | |
| +14.89% | +13.85% | |
| +14.25% | +12.26% | |
| +16.73% | — | |
| +14.84% | +15.60% | |
| +14.46% | +14.52% | |
| +14.58% | +13.74% | |
| Risk | ||
| 15.76% | 15.62% | |
| 0.79 | 0.43 | |
| 1.13 | 0.59 | |
| -30.89% | -23.65% | |
| S&P 500 | — | |
| -0.58% | +3.42% | |
| 0.97 | 0.95 | |
| 94.7% | 105.9% | |
| 96.3% | 93.6% | |
| 2.38% | 2.39% | |
| ₹741.03Cr | ₹1,161Cr | |
| — | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 12% | 45% | |
| Kinjal Desai · 8.2y | — | |
| 28 Jul 2015 | — | |
| — | — | |
| — | — | |
| 12.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.